Balchem CORP 10-Q quarterly reports

Balchem Corporation reported a 16.6% increase in net earnings for the second quarter of 2026, driven by robust sales growth across its Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products segments.

Balchem Corporation reported strong Q1 2026 results with net sales of $270.7 million, an 8.1% increase year-over-year, driven by growth in all business segments.

Balchem Corporation reports robust financial performance for Q3 2025, with significant increases in net sales and earnings across all segments, driven by favorable market conditions and strategic initiatives.

Balchem Corporation announced significant increases in net sales and net earnings for the second quarter and first half of 2025, fueled by robust performance across all its business segments.

Balchem Corporation's Q1 2025 net earnings increased by 27.8% year-over-year, driven by sales growth across all segments and improved gross margins.

Balchem Corporation's third quarter 2024 results show a 16.4% increase in net earnings compared to the same period last year, driven by growth in the Human Nutrition & Health segment.

Balchem Corporation's second quarter 2024 results show a slight increase in net sales and improved gross margins, primarily driven by growth in the Human Nutrition & Health segment.

Balchem Corporation's first quarter 2024 results show a significant increase in net earnings, primarily driven by the Human Nutrition and Health segment.